RG
UTHR icon

Rathbones Group’s United Therapeutics UTHR Stock Holding History

Rathbones Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Buy
4,289
+11
+0.3% +$6.2K 0.01% 294
2026
Q1 		$2.54M Hold
4,278
– – 0.01% 277
2025
Q4 		$2.08M Buy
4,278
+18
+0.4% +$8.38K 0.01% 298
2025
Q3 		$1.79M Hold
4,260
– – 0.01% 298
2025
Q2 		$1.22M Hold
4,260
– – 0.01% 324
2025
Q1 		$1.31M Hold
4,260
– – 0.01% 310
2024
Q4 		$1.5M Hold
4,260
– – 0.01% 304
2024
Q3 		$1.53M Hold
4,260
– – 0.01% 290
2024
Q2 		$1.36M Hold
4,260
– – 0.01% 294
2024
Q1 		$979K Hold
4,260
– – 0.01% 327
2023
Q4 		$937K Hold
4,260
– – 0.01% 324
2023
Q3 		$962K Buy
+4,260
New +$981K 0.01% 317

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Rathbones Group's UTHR Position: Q2 2026 in Review

Rathbones Group increased its United Therapeutics (UTHR) stake by 0.26% in Q2 2026, buying an estimated $6.2K and bringing the position to 4,289 shares worth $2.32M. The position accounts for 0.01% of the portfolio, ranked #294.

Rathbones Group first reported a position in UTHR in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.54M in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Rathbones Group held 4,289 shares of United Therapeutics worth $2.32M as of Q2 2026.
  • Rathbones Group bought 11 United Therapeutics shares in Q2 2026, an estimated $6.2K.
  • United Therapeutics made up 0.01% of Rathbones Group's portfolio in Q2 2026, its #294 holding.
  • Rathbones Group first reported a position in United Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • Rathbones Group's United Therapeutics position peaked at $2.54M in Q1 2026.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.